This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24/7 Access
Digital & In-Person

Digital Weeks

mRNA Technologies, Therapeutics and Vaccines Digital Week

June 28-30, 2021
A complimentary 3-day webcast series where Industry leaders and service providers will showcase the power and diversity of mRNA technologies and applications across discovery/R&D, manufacturing and delivery.

TIDES Digital Week

May 2022
A complimentary 4-day webinar series where industry leaders and service providers uncover leading strategies for expediting R&D and improving CMC efficiency.



Hybrid Event: September 20-30, 2021
Live Event: September 20-23 in Boston, MA
The industry's largest & most renowned event to accelerate your therapeutics to market. Leading strategies for expediting R&D and improving CMC efficiency. Unparalleled access to new data & case studies from globally recognized speakers across the entire landscape of oligonucleotides, peptides, mRNA, genome editing, drug delivery, and partnerships – from discovery to market. 

TIDES Europe

November 2-5, 2021 | Vienna, Austria
The industry's leading event in Europe to accelerate therapeutics to market by expediting R&D, improving CMC efficiency, and building new partnerships. Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region. 

Training Courses

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration

September 14-16
Learn how to develop an evolving control strategy for your drug substance — from early development to registration. The course will also discuss the issues and risks that can be developed, addressed and mitigated during development

Introduction to Oligonucleotide Conjugate Strategies

October 26-28
Understand how to best design oligonucleotide conjugates — from simple starting building blocks to the full oligonucleotide conjugate. With full consideration of the biological behavior of both the finished molecule and all of its individual components.

Expert Opinion Webinars

Characterization of Shared Immunogenic Frameshift Mutations in Cancers with Microsatellite Instability

Sponsored by Genscript

Wednesday, July 21 @ 11:00am EST

Expert Speaker: 

-Dr. Cansu Cimen Bozkus, Icahn School of Medicine at Mount Sinai